Impact of COVID-19 Related Restrictions on Infections in Children with Cancer or after Hematopoietic SCT
Standard
Impact of COVID-19 Related Restrictions on Infections in Children with Cancer or after Hematopoietic SCT : A Monocentric, Retrospective Study. / Hauch, Richard; Hinrichs, Malena; Ruhwald, Rebecca; Schrum, Johanna; Rutkowski, Stefan; Woessmann, Wilhelm; Winkler, Beate.
In: KLIN PADIATR, Vol. 235, No. 3, 05.2023, p. 159-166.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Impact of COVID-19 Related Restrictions on Infections in Children with Cancer or after Hematopoietic SCT
T2 - A Monocentric, Retrospective Study
AU - Hauch, Richard
AU - Hinrichs, Malena
AU - Ruhwald, Rebecca
AU - Schrum, Johanna
AU - Rutkowski, Stefan
AU - Woessmann, Wilhelm
AU - Winkler, Beate
N1 - Thieme. All rights reserved.
PY - 2023/5
Y1 - 2023/5
N2 - Background Infections are a major concern for immunocompromised children. We investigated whether non-pharmaceutical interventions (NPIs) implemented in the general population during the coronavirus disease 2019 (COVID-19) pandemic in Germany had an impact on frequency, type and severity of infections in these patients.Patients and methods We analyzed all admissions to the clinic of pediatric hematology, oncology and stem cell transplantation (SCT) with (suspected) infection or fever of unknown origin (FUO) from 2018 to 2021.Results We compared a 27-month period before NPIs (Pre-COVID: 01/2018–03/2020; 1041 cases) with a 12-month period with underlying NPIs (COVID: 04/2020–03/2021; 420 cases). During the COVID period the number of in-patient stays with FUO or infections decreased (38,6 cases/month vs. 35,0 cases/month), the median duration of hospital stays was longer (8 d (CI95: 7–8 d) vs. 9 d (CI95: 8–10 d) P=0,02)), the mean number of antibiotics per case increased (2,1 (CI95: 2,0–2,2) vs. 2,5 (CI95: 2,3–2,7); P=0,003)) and a substantial reduction of viral respiratory and gastrointestinal infections per case was seen (0,24 vs. 0,13; P<0,001). Notably, there was no detection of respiratory syncytial virus, influenza and norovirus, between May 2020 and March 2021. Based on need of intensive care measures and further parameters we conclude that severe (bacterial) infections were not significantly reduced by NPIs.Conclusions Introduction of NPIs in the general population during the COVID-pandemic substantially reduced viral respiratory and gastrointestinal infections in immunocompromised patients, while severe (bacterial) infections were not prevented.
AB - Background Infections are a major concern for immunocompromised children. We investigated whether non-pharmaceutical interventions (NPIs) implemented in the general population during the coronavirus disease 2019 (COVID-19) pandemic in Germany had an impact on frequency, type and severity of infections in these patients.Patients and methods We analyzed all admissions to the clinic of pediatric hematology, oncology and stem cell transplantation (SCT) with (suspected) infection or fever of unknown origin (FUO) from 2018 to 2021.Results We compared a 27-month period before NPIs (Pre-COVID: 01/2018–03/2020; 1041 cases) with a 12-month period with underlying NPIs (COVID: 04/2020–03/2021; 420 cases). During the COVID period the number of in-patient stays with FUO or infections decreased (38,6 cases/month vs. 35,0 cases/month), the median duration of hospital stays was longer (8 d (CI95: 7–8 d) vs. 9 d (CI95: 8–10 d) P=0,02)), the mean number of antibiotics per case increased (2,1 (CI95: 2,0–2,2) vs. 2,5 (CI95: 2,3–2,7); P=0,003)) and a substantial reduction of viral respiratory and gastrointestinal infections per case was seen (0,24 vs. 0,13; P<0,001). Notably, there was no detection of respiratory syncytial virus, influenza and norovirus, between May 2020 and March 2021. Based on need of intensive care measures and further parameters we conclude that severe (bacterial) infections were not significantly reduced by NPIs.Conclusions Introduction of NPIs in the general population during the COVID-pandemic substantially reduced viral respiratory and gastrointestinal infections in immunocompromised patients, while severe (bacterial) infections were not prevented.
KW - Humans
KW - Child
KW - COVID-19/epidemiology
KW - Neoplasms/epidemiology
KW - Hematopoietic Stem Cell Transplantation
KW - Medical Oncology
KW - Ambulatory Care Facilities
KW - Respiratory Tract Infections/epidemiology
U2 - 10.1055/a-2000-5388
DO - 10.1055/a-2000-5388
M3 - SCORING: Journal article
C2 - 36848939
VL - 235
SP - 159
EP - 166
JO - KLIN PADIATR
JF - KLIN PADIATR
SN - 0300-8630
IS - 3
ER -